LRMR SG&A Expense Growth
Larimar Therapeutics Inc · SG&A Expense Growth
LRMR SG&A Expense Growth
Latest reported3.75%period ending
LRMR FY SG&A Growth (YoY) (0.00% → 3.75%)
Latest values, visible window
High-resolution chart · PNG
LRMR sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 3.7531% | |
| 25.0142% | |
| 14.7605% | |
| 1.7151% | |
| 5.8963% | |
| 370.1733% | |
| -81.2558% | |
| 8.2357% | |
| -30.2754% | |
| -10.4% | |
| 134.922% | |
| 93.5108% | |
| 88.1485% | |
| 27.9908% | |
| 0% |